OCUGEN, BHARAT BIOTECH'S AMERICAN PARTNER SUBMITS MASTER FILE ON COVAXIN TO THE US FDA

Highlights

• Ocugen has submitted a "Master File" to the US Food and Drug Administration before seeking an emergency use authorisation (EUA) in the United States

• The Bharat Biotech told the government of India that it has already submitted 90% of documents to WHO in order to obtain emergency use listing (EUL)

Ocugen, the US-based partner of Indian biotechnology company Bharat Biotech for COVI....